Webinar: Navigating the FDA review process
When: February 29, 2012
This webinar was designed as an advocates’ guide to the US Food and Drug Administration (FDA) review of data regarding TDF/FTC (Truvada) for HIV prevention. US-based advocates discussed steps for involvement in the process; international advocates may be interested in the topic as well, given that US FDA regulatory decisions are closely watched in many countries.
We also have a new document about the FDA regulatory process ready. An Advocate's Primer for Public Participation gives an overview of the regulatory process and provides information on how all of us can be involved.
Read the primer.